Stock listing
Tradegate:07X Annovis Bio, Inc. Aktie
German listing (Tradegate) of Annovis Bio, Inc. · home listing NYSE:ANVS
Follow Annovis Bio, Inc. into a list and get an email when it puts out news.
Home listing price · NYSE:ANVS
$1.21 USD +0.12 (+11.0%)
Close on Nov 4, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NYSE:ANVS
- Day range
- $1.10 – $1.25 USDNov 4, 2026
- Volume
- 1.35M sharesNov 4, 2026
- Market cap
- $51.64M USDAt the close on Nov 4, 2026 · price × 42.68M shares outstanding
- 52-week range
- $0.93 – $5.50 USDLowest and highest trades, Nov 5, 2025 – Nov 4, 2026
- Traded on an average day
- $1.24M USDMedian day 679,120 shares · last 3 months, Aug 4, 2026 – Nov 4, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:ANVS · Home | $1.21 USD | +0.12 (+11.0%) | 1,345,369 | $1.12 | $1.25 | $1.10 | $1.09 | Close on Nov 4, 2026 |
| Frankfurt:07X | €0.89 EUR | -0.009 (-1.0%) | — | €0.89 | €0.89 | €0.89 | €0.899 | Close on Oct 30, 2026 |
Daily closes
Last 3 months, Aug 4, 2026 – Nov 4, 2026 · NYSE:ANVS · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $1.21 | +0.12 | +11.0% | $1.12 | $1.25 | $1.10 | 1,345,369 | |
| $1.09 | +0.01 | +0.9% | $1.07 | $1.15 | $1.06 | 680,339 | |
| $1.08 | -0.05 | -4.4% | $1.17 | $1.395 | $1.05 | 3,003,375 | |
| $1.13 | +0.11 | +10.8% | $1.02 | $1.17 | $1.01 | 1,481,660 | |
| $1.02 | 0.00 | 0.0% | $1.01 | $1.05 | $1.00 | 1,482,414 | |
| $1.02 | +0.02 | +2.0% | $0.98 | $1.03 | $0.98 | 913,375 | |
| $1.00 | +0.043 | +4.5% | $0.95 | $1.03 | $0.95 | 912,813 | |
| $0.957 | -0.042 | -4.2% | $1.00 | $1.00 | $0.93 | 593,135 | |
| $0.999 | +0.008 | +0.8% | $0.99 | $1.01 | $0.961 | 315,625 | |
| $0.992 | -0.001 | -0.2% | $0.99 | $1.05 | $0.98 | 448,442 | |
| $0.993 | +0.015 | +1.5% | $1.00 | $1.04 | $0.988 | 546,328 | |
| $0.978 | +0.018 | +1.9% | $0.96 | $1.04 | $0.96 | 703,977 | |
| $0.96 | -0.03 | -3.0% | $0.995 | $1.04 | $0.95 | 641,350 | |
| $0.99 | -0.06 | -5.7% | $1.06 | $1.08 | $0.99 | 641,400 | |
| $1.05 | +0.03 | +2.9% | $1.04 | $1.08 | $1.01 | 572,200 | |
| $1.02 | -0.04 | -3.8% | $1.05 | $1.08 | $1.01 | 844,200 | |
| $1.06 | -0.09 | -7.8% | $1.15 | $1.15 | $1.05 | 850,800 | |
| $1.15 | -0.06 | -5.0% | $1.21 | $1.21 | $1.14 | 460,200 | |
| $1.21 | +0.04 | +3.4% | $1.17 | $1.24 | $1.14 | 521,900 | |
| $1.17 | -0.04 | -3.3% | $1.21 | $1.21 | $1.14 | 815,400 | |
| $1.21 | +0.03 | +2.5% | $1.17 | $1.23 | $1.16 | 429,700 | |
| $1.18 | -0.02 | -1.7% | $1.20 | $1.24 | $1.17 | 538,700 | |
| $1.20 | +0.02 | +1.7% | $1.16 | $1.20 | $1.14 | 657,600 | |
| $1.18 | +0.01 | +0.9% | $1.19 | $1.20 | $1.14 | 648,500 | |
| $1.17 | -0.10 | -7.9% | $1.27 | $1.28 | $1.16 | 1,201,800 | |
| $1.27 | -0.03 | -2.3% | $1.30 | $1.34 | $1.27 | 572,500 | |
| $1.30 | -0.08 | -5.8% | $1.39 | $1.41 | $1.30 | 812,000 | |
| $1.38 | +0.07 | +5.3% | $1.32 | $1.43 | $1.30 | 1,190,000 | |
| $1.31 | -0.02 | -1.5% | $1.35 | $1.36 | $1.31 | 573,500 | |
| $1.33 | +0.06 | +4.7% | $1.27 | $1.34 | $1.23 | 853,900 | |
| $1.27 | +0.01 | +0.8% | $1.30 | $1.33 | $1.24 | 1,144,300 | |
| $1.26 | +0.07 | +5.9% | $1.19 | $1.30 | $1.19 | 1,214,700 | |
| $1.19 | +0.05 | +4.4% | $1.16 | $1.22 | $1.16 | 882,300 | |
| $1.14 | +0.04 | +3.6% | $1.12 | $1.16 | $1.09 | 677,900 | |
| $1.10 | +0.06 | +5.8% | $1.10 | $1.17 | $1.08 | 1,521,800 | |
| $1.04 | -0.08 | -7.1% | $1.12 | $1.13 | $1.04 | 1,431,100 | |
| $1.12 | -0.02 | -1.8% | $1.14 | $1.14 | $1.10 | 823,200 | |
| $1.14 | +0.02 | +1.8% | $1.10 | $1.17 | $1.10 | 1,201,700 | |
| $1.12 | -0.07 | -5.9% | $1.20 | $1.23 | $1.10 | 1,893,400 | |
| $1.19 | -0.03 | -2.5% | $1.21 | $1.26 | $1.17 | 1,337,500 | |
| $1.22 | -0.08 | -6.2% | $1.31 | $1.32 | $1.22 | 1,743,600 | |
| $1.30 | -0.09 | -6.5% | $1.39 | $1.40 | $1.30 | 1,962,800 | |
| $1.39 | +0.01 | +0.7% | $1.40 | $1.44 | $1.38 | 1,532,600 | |
| $1.38 | -0.32 | -18.8% | $1.65 | $1.68 | $1.32 | 7,332,100 | |
| $1.70 | +0.01 | +0.6% | $1.71 | $1.76 | $1.69 | 606,800 | |
| $1.69 | -0.03 | -1.7% | $1.73 | $1.73 | $1.67 | 457,200 | |
| $1.72 | 0.00 | 0.0% | $1.72 | $1.78 | $1.70 | 425,500 | |
| $1.72 | -0.09 | -5.0% | $1.78 | $1.83 | $1.71 | 498,400 | |
| $1.81 | +0.03 | +1.7% | $1.76 | $1.81 | $1.76 | 292,300 | |
| $1.78 | -0.04 | -2.2% | $1.84 | $1.86 | $1.76 | 233,600 | |
| $1.82 | +0.07 | +4.0% | $1.76 | $1.825 | $1.76 | 560,283 | |
| $1.75 | -0.07 | -3.8% | $1.83 | $1.83 | $1.74 | 670,723 | |
| $1.82 | +0.03 | +1.7% | $1.78 | $1.84 | $1.77 | 618,600 | |
| $1.79 | -0.06 | -3.2% | $1.84 | $1.89 | $1.78 | 548,800 | |
| $1.85 | +0.05 | +2.8% | $1.90 | $1.90 | $1.79 | 746,800 | |
| $1.80 | +0.06 | +3.4% | $1.75 | $1.82 | $1.74 | 449,500 | |
| $1.74 | -0.11 | -5.9% | $1.82 | $1.85 | $1.74 | 662,000 | |
| $1.85 | +0.06 | +3.4% | $1.83 | $1.90 | $1.80 | 949,700 | |
| $1.79 | -0.01 | -0.6% | $1.84 | $1.86 | $1.75 | 712,000 | |
| $1.80 | -0.09 | -4.8% | $1.87 | $1.90 | $1.80 | 502,300 | |
| $1.89 | 0.00 | 0.0% | $1.91 | $1.91 | $1.86 | 351,700 | |
| $1.89 | +0.01 | +0.5% | $1.90 | $1.90 | $1.85 | 321,100 | |
| $1.88 | +0.02 | +1.1% | $1.90 | $1.95 | $1.85 | 557,300 | |
| $1.86 | -0.01 | -0.5% | $1.91 | $1.91 | $1.81 | 317,200 | |
| $1.87 | 0.00 | 0.0% | $1.90 | $1.98 | $1.86 | 1,100,300 | |
| $1.87 | +0.15 | +8.7% | $1.75 | $1.91 | $1.72 | 809,000 |
- Ticker
- Tradegate:07X
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- Tradegate
- Currency
- EUR
What changed lately
Latest news release · Nov 4, 2026
Annovis Announces Launch of Proposed Public Offering
Latest deck · Jan 28, 2026
Corporate Update (January 2026)
Corporate update · 26 slides
Latest news
Annovis Bio, Inc. Receives Continued Listing Standard Notice from the NYSE
Oct 30, 2026
Closed $1.08 (-4.4%) on Nov 2, 2026
Annovis to Participate in U.S. Biotech Day 2026 and Pharma Partnering Summit 2026
Oct 29, 2026
Closed $1.02 (0.0%) on Oct 29, 2026
Annovis to Attend the CTAD 2026 with Three Presentations
Oct 22, 2026
Closed $0.992 (-0.2%) on Oct 22, 2026
Annovis Bio Announces Partnership with Weave Bio, AI Regulatory Platform, in Preparation of NDA for Buntanetap in Alzheimer's disease
Sep 24, 2026
Closed $1.33 (+4.7%) on Sep 24, 2026
Annovis to Host Corporate Update Webinar on September 2, 2026
Aug 25, 2026
Closed $1.82 (+4.0%) on Aug 25, 2026
Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results
Aug 14, 2026
Closed $1.85 (+3.4%) on Aug 14, 2026
Annovis Reaches Full Enrollment in Pivotal Phase 3 Trial of Buntanetap for Early Alzheimer’s Disease
Jul 7, 2026
Closed $1.92 (-2.5%) on Jul 7, 2026
Annovis Appoints Cheng Fang, Ph.D., as Chief Scientific Officer
Jul 1, 2026
Closed $1.92 (+3.2%) on Jul 1, 2026
Annovis Bio Regains NYSE Listing Compliance
May 26, 2026
Closed $2.06 (-7.6%) on May 26, 2026
Financings
Public offering of shares of common stock (or pre-funded warrants) and accompanying warrants
Nov 4, 2026
Announced: Canaccord Genuity
Dealers: Canaccord Genuity (lead)
Use of proceeds: Continued clinical development of buntanetap in Alzheimer's and Parkinson's studies, plus working capital and general corporate purposes
Decks
Corporate Update (January 2026)
Corporate update · 26 slides · Jan 28, 2026
Corporate Update (December 2024)
Corporate update · 23 slides · Dec 11, 2024
Corporate Update (June 2024)
Corporate update · 15 slides · Jun 11, 2024
Investor Presentation (February 2023)
Investor deck · 28 slides · Feb 13, 2023
Annovis Bio, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 33 in the last 12 months · 52 in all · newest Nov 4, 2026 · oldest 2025
- Decks
- 11 decks · latest Jan 28, 2026
Where Annovis Bio, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:ANVS · Home listing | NYSE | United States | USD |
| LS Exchange:A2PNH2 | LS Exchange | Germany | EUR |
| gettex:07X | gettex | Germany | EUR |
| Lang & Schwarz:A2PNH2 | Lang & Schwarz | Germany | EUR |
| BOATS:ANVS | BOATS | United States | USD |
| Dusseldorf:07X | Dusseldorf | Germany | EUR |
| Frankfurt:07X | Frankfurt | Germany | EUR |
| Munich:07X | Munich | Germany | EUR |
| Stuttgart:07X | Stuttgart | Germany | EUR |
| Tradegate:07X · This page | Tradegate | Germany | EUR |
Log in to ask 6ix AI your own questions about Annovis Bio, Inc.